Your Search for 'Diabetes' returned 8851 results - Page 1 of 443

• Diabetes Diagnostics - Global Strategic Business Report

  EURO€ 3,717.00USD$ 4,200.00GBP£ 2,478.00AUD$ 5,808.00JPY¥ 503,659.00SEK 33 040,00CHF 5'531.00CAD$ 5,387.00 Global Industry Analysts, Inc, Apr 2012 , Pages: 492
  Diabetes Diagnostics - Global Strategic Business Report This report analyzes the worldwide markets for Diabetes Diagnostics in US$ Million by the following Product Segments: - Blood Glucose Testing ...

• Diabetes Partnering 2007-2013

  EURO€ 1,533.00USD$ 1,995.00GBP£ 1,290.00AUD$ 1,951.00JPY¥ 196,972.00SEK 13 099,00CHF 1'880.00CAD$ 2,033.00 CurrentPartnering, Jan 2013 , Pages: 300
  Diabetes Partnering 2007-2013 The Diabetes Partnering 2007-2013 provides understanding and access to the diabetes partnering deals and agreements entered into by the worlds leading healthcare ...

• Research Report on China's Diabetes Drug Market, 2013-2017

  EURO€ 2,152.00USD$ 2,800.00GBP£ 1,811.00AUD$ 2,739.00JPY¥ 276,452.00SEK 18 384,00CHF 2'639.00CAD$ 2,853.00 China Research & Intelligence, Dec 2012 , Pages: 50
  Research Report on China's Diabetes Drug Market, 2013-2017 Diabetes refers to a series of metabolic disorder syndrome such as sugars, proteins, fat, water and electrolyte that are triggered by islet ...

• Diabetes Partnering 2007-2012

  EURO€ 1,533.00USD$ 1,995.00GBP£ 1,290.00AUD$ 1,951.00JPY¥ 196,972.00SEK 13 099,00CHF 1'880.00CAD$ 2,033.00 CurrentPartnering, Jun 2012 , Pages: 300
  Diabetes Partnering 2007-2012 The Diabetes Partnering 2007-2012 provides understanding and access to the diabetes partnering deals and agreements entered into by the worlds leading healthcare ...

• Global Diabetes Devices & Drugs Market (2011- 2016)

  EURO€ 3,378.00USD$ 4,395.00GBP£ 2,842.00AUD$ 4,299.00JPY¥ 433,931.00SEK 28 857,00CHF 4'142.00CAD$ 4,478.00 Transparency Market Research, Nov 2011 , Pages: 122
  Global Diabetes Devices & Drugs Market (2011- 2016) The report contains the global scenario of Diabetes market discussing its details and market figures. The report provides market size and forecast ...

• Global Diabetes Devices Market And Diabetes Drugs Market - Industry Scenario, Trends, Analysis, Size, Share & Forecast 2011 - 2018

  EURO€ 3,378.00USD$ 4,395.00GBP£ 2,842.00AUD$ 4,299.00JPY¥ 433,931.00SEK 28 857,00CHF 4'142.00CAD$ 4,478.00 Transparency Market Research, Sep 2012 , Pages: 162
  Global Diabetes Devices Market And Diabetes Drugs Market - Industry Scenario, Trends, Analysis, Size, Share & Forecast 2011 - 2018 This report is an effort to identify factors, which will be the ...

• Diabetes, Metabolic Syndrome and Cardiovascular Disease

  EURO€ 2,613.00USD$ 3,400.00GBP£ 2,199.00AUD$ 3,325.00JPY¥ 335,692.00SEK 22 324,00CHF 3'205.00CAD$ 3,465.00 TriMark Publications, Dec 2012 , Pages: 219
  Diabetes, Metabolic Syndrome and Cardiovascular Disease There has been a dramatic increase in the incidence of diabetes worldwide, which has been exacerbated by the growing obesity problem across the ...

• Staged Diabetes Management

  EURO€ 119.00USD$ 155.00GBP£ 100.00AUD$ 151.00JPY¥ 15,266.00SEK 1 015,00CHF 146.00CAD$ 158.00 John Wiley and Sons Ltd, Dec 2011 , Pages: 300
  Staged Diabetes Management This new edition of the successful Staged Diabetes Management will again address the prominent issues of primary care diabetes management based on the International ...

• Chinese Markets for Diabetes Drugs

  EURO€ 4,280.00USD$ 4,000.00GBP£ 2,432.00AUD$ 5,823.00JPY¥ 490,826.00SEK 34 516,00CHF 5'745.00CAD$ 5,347.00 AMID Co, Sep 2012 , Pages: 185
  Chinese Markets for Diabetes Drugs China's demand for diabetes drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new ...

• BRIC Diabetes Drugs Market (2010-2015)

  EURO€ 3,574.00USD$ 4,650.00GBP£ 3,007.00AUD$ 4,548.00JPY¥ 459,108.00SEK 30 531,00CHF 4'383.00CAD$ 4,738.00 Markets and Markets, Apr 2010 , Pages: 118
  BRIC Diabetes Drugs Market (2010-2015) The prevalence of diabetes is on the rise across the globe due to increased life expectancy, changing lifestyles, and the rising incidence of obesity. Brazil's ...

• Global Type 1 Diabetes Epidemiology and Patient Flow Analysis - 2012

  EURO€ 884.00USD$ 1,150.00GBP£ 744.00AUD$ 1,125.00JPY¥ 113,543.00SEK 7 551,00CHF 1'084.00CAD$ 1,172.00 Fore Pharma, Oct 2012 , Pages: 24
  Global Type 1 Diabetes Epidemiology and Patient Flow Analysis - 2012 Fore Pharma announced the results of its Type 1 Diabetes patient population study in a new report ‘Global Type 1 Diabetes ...

• Blood Glucose Testing and Diabetes Management

  EURO€ 2,613.00USD$ 3,400.00GBP£ 2,199.00AUD$ 3,325.00JPY¥ 335,692.00SEK 22 324,00CHF 3'205.00CAD$ 3,465.00 TriMark Publications, Jun 2012 , Pages: 262
  Blood Glucose Testing and Diabetes Management There has been a dramatic increase in the incidence of diabetes worldwide, which has been exacerbated by the growing obesity problem across the globe ...

• The Diabetes Market Outlook to 2016

  EURO€ 2,948.00USD$ 3,835.00GBP£ 2,480.00AUD$ 3,751.00JPY¥ 378,641.00SEK 25 180,00CHF 3'615.00CAD$ 3,908.00 Scripp Business Insights, May 2011 , Pages: 132
  The Diabetes Market Outlook to 2016 This report provides comprehensive coverage of the diabetes market, incorporating a disease overview and detailed epidemiological analyses of the therapy area. It ...

• European Diabetes Therapeutics Market

  EURO€ 4,996.00USD$ 6,500.00GBP£ 4,203.00AUD$ 6,357.00JPY¥ 641,764.00SEK 42 678,00CHF 6'126.00CAD$ 6,623.00 Frost & Sullivan, Sep 2011 , Pages: 151
  European Diabetes Therapeutics Market How Far Would it Go: New Classes of Drugs to Emerge by 2014 The research study "European Diabetes Therapeutics Market" aims to thoroughly assess and analyse ...

• Type 2 Diabetes (Event Driven)

  EURO€ 11,530.00USD$ 15,000.00GBP£ 9,700.00AUD$ 14,671.00JPY¥ 1,480,995.00SEK 98 488,00CHF 14'138.00CAD$ 15,285.00 Decision Resources, Inc, Nov 2012 , Pages: 263
  Type 2 Diabetes (Event Driven) The rapidly expanding type 2 diabetes population, coupled with an unmet need for drugs that can effectively control the disease in the long term, promotes sustained ...

• Diabetes Care Devices Market to 2018 - Integrated Insulin Pumps with Continuous Glucose Monitoring Technology to Add a New Dimension to Diabetes Management

  EURO€ 2,690.00USD$ 3,500.00GBP£ 2,263.00AUD$ 3,423.00JPY¥ 345,565.00SEK 22 980,00CHF 3'299.00CAD$ 3,566.00 GBI Research, Aug 2012 , Pages: 107
  Diabetes Care Devices Market to 2018 - Integrated Insulin Pumps with Continuous Glucose Monitoring Technology to Add a New Dimension to Diabetes Management GBI Research’s report, “Diabetes Care ...

• Lexicon's LX-4211 - a novel mechanism to treat diabetes

  EURO€ 1,537.00USD$ 2,000.00GBP£ 1,293.00AUD$ 1,956.00JPY¥ 197,466.00SEK 13 132,00CHF 1'885.00CAD$ 2,038.00 LifeTech Research, Dec 2011 , Pages: 29
  Lexicon's LX-4211 - a novel mechanism to treat diabetes Lexicon’s LX-4211 is in phase II development for the treatment of type 2 diabetes. It belongs to a novel class of agents that inhibits sodium ...

• Cell and Stem Cell Therapies for Diabetes

  EURO€ 1,268.00USD$ 1,650.00GBP£ 1,067.00AUD$ 1,614.00JPY¥ 162,909.00SEK 10 834,00CHF 1'555.00CAD$ 1,681.00 BioPolaris, Feb 2010 , Pages: 58
  Cell and Stem Cell Therapies for Diabetes In 2030, three leading countries with diabetes population, India, China and the USA, will have over 150 million people with diabetes. For the USA ...

• Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2012

  EURO€ 1,537.00USD$ 2,000.00GBP£ 1,293.00AUD$ 1,956.00JPY¥ 197,466.00SEK 13 132,00CHF 1'885.00CAD$ 2,038.00 Global Markets Direct, Aug 2012 , Pages: 335
  Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2012 Type 1 Diabetes (Juvenile Diabetes) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Type 1 Diabetes (Juvenile Diabetes ...

• Diabetes - Pipeline Review, H1 2013

  EURO€ 1,537.00USD$ 2,000.00GBP£ 1,293.00AUD$ 1,956.00JPY¥ 197,466.00SEK 13 132,00CHF 1'885.00CAD$ 2,038.00 Global Markets Direct, Mar 2013 , Pages: 359
  Diabetes - Pipeline Review, H1 2013 Diabetes – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Diabetes - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic ...